The presenters discuss their work on optical imaging of the inner ear to enable progress in understanding, diagnosing, and treating human sensorineural hearing loss (SNHL). Next, they illustrate their approach to develop personalized therapies for SNHL, using vestibular schwannoma as an example. Finally, they demonstrate the promise of gene therapy, nanotechnology, and computational drug repositioning.

This course was presented and recorded at the 2019 ASHA Convention.

Learning Objectives
You will be able to:

• identify optical methodologies that allow visualization of individual cells within the 3D intact inner ear without contrast dyes
• discuss why Anc80 is a promising viral vector for gene transfer in the inner ear
• review computational repositioning of FDA approved drugs for hearing disorders

What is Included?

You'll get online access to all the course content, including the full video, handouts, and references so you can access it from anywhere!

Assessment Type

Self-assessment—Think about what you learned and report on the Completion Form how you will use your new knowledge.

Related Courses

View other audiology sessions presented and recorded at the 2019 ASHA Convention, available through the ASHA Learning Pass subscription or as an a la carte purchase.